{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:16:12Z","timestamp":1759796172531,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.prp.2022.153937","type":"journal-article","created":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T11:36:16Z","timestamp":1651836976000},"page":"153937","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Could double stain for p53\/CK20 be a useful diagnostic tool for the appropriate classification of flat urothelial lesions?"],"prefix":"10.1016","volume":"234","author":[{"given":"Luisa","family":"Di Sciascio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Ambrosi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tania","family":"Franceschini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Giunchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenia","family":"Franchini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Massari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico Mineo","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Colecchia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelangelo","family":"Fiorentino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Costantino","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2016","series-title":"WHO Classification of Tumours of the Urinary System and Male Genital Organs","author":"Moch","key":"10.1016\/j.prp.2022.153937_bib1"},{"key":"10.1016\/j.prp.2022.153937_bib2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s002920050390","article-title":"Revisions in the WHO histological classification of urothelial bladder tumors and flat urothelial lesions","volume":"21","author":"Helpap","year":"2000","journal-title":"Pathologe"},{"key":"10.1016\/j.prp.2022.153937_bib3","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.humpath.2009.07.002","article-title":"Urothelial dysplasia and other flat lesions of the urinary bladder: clinicopathologic and molecular features","volume":"41","author":"Hodges","year":"2010","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2022.153937_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00428-001-0577-6","article-title":"Preneoplastic nonpapillary lesions and conditions of the urinary bladder: an update based on the Ancona International Consultation","volume":"440","author":"Lopez-Beltran","year":"2002","journal-title":"Virchows Arch."},{"key":"10.1016\/j.prp.2022.153937_bib5","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1097\/00000478-199812000-00001","article-title":"The World Health Organization\/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee","volume":"22","author":"Epstein","year":"1998","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2022.153937_bib6","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1002\/(SICI)1097-0142(19990601)85:11<2469::AID-CNCR24>3.0.CO;2-U","article-title":"Survival of patients with carcinoma in situ of the urinary bladder","volume":"85","author":"Cheng","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2022.153937_bib7","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/00000478-199904000-00009","article-title":"Natural history of urothelial dysplasia of the bladder","volume":"23","author":"Cheng","year":"1999","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2022.153937_bib8","first-page":"1073","article-title":"Epithelial lesions of the urinary bladder in 313 autopsy cases","volume":"78","author":"Shirai","year":"1987","journal-title":"Jpn. J. Cancer Res."},{"key":"10.1016\/j.prp.2022.153937_bib9","first-page":"305","article-title":"Evolving concepts and use of immunohistochemical biomarkers in flat non-neoplastic urothelial lesions: WHO 2016 classification update with diagnostic algorithm","volume":"23","author":"Sanguedolce","year":"2018"},{"key":"10.1016\/j.prp.2022.153937_bib10","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/jcp.56.2.91","article-title":"Classification and grading of the non-invasive urothelial neoplasms: recent advances and controversies","volume":"56","author":"Montironi","year":"2003","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.prp.2022.153937_bib11","first-page":"301","article-title":"Immunohistochemical markers in the evaluation of tumors of the urinary bladder: a review","volume":"27","author":"Emerson","year":"2005","journal-title":"Anal. Quant. Cytol. Histol."},{"key":"10.1016\/j.prp.2022.153937_bib12","first-page":"380","article-title":"Immunohistochemical markers in the evaluation of tumors of the urinary bladder: a review","volume":"29","author":"Requena","year":"2007","journal-title":"Anal. Quant. Cytol. Histol."},{"key":"10.1016\/j.prp.2022.153937_bib13","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1097\/00000478-200108000-00013","article-title":"Discriminatory immunohistochemical staining of urothelial carcinoma in situ and non-neoplastic urothelium: an analysis of cytokeratin 20, p53, and CD44 antigens","volume":"25","author":"McKenney","year":"2001","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2022.153937_bib14","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1440-1827.2005.01821.x","article-title":"Utility of cytokeratin 20 and Ki-67 as markers of urothelial dysplasia","volume":"55","author":"Kunju","year":"2005","journal-title":"Pathol. Int."},{"key":"10.1016\/j.prp.2022.153937_bib15","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1046\/j.1464-410X.1996.23511.x","article-title":"Cytokeratin 20 as an objective marker of urothelial dysplasia","volume":"78","author":"Harnden","year":"1996","journal-title":"Br. J. Urol."},{"key":"10.1016\/j.prp.2022.153937_bib16","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/S0022-5347(01)65550-2","article-title":"Clonal analysis of human recurrent superficial bladder cancer by immunohistochemistry of P53 and retinoblastoma proteins","volume":"156","author":"Chern","year":"1996","journal-title":"J. Urol."},{"key":"10.1016\/j.prp.2022.153937_bib17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13000-020-00984-2","article-title":"CK20 versus AMACR and p53 immunostains in evaluation of urothelial carcinoma in situ and reactive atypia","volume":"15","author":"Neal","year":"2020","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.prp.2022.153937_bib18","doi-asserted-by":"crossref","first-page":"64","DOI":"10.5858\/arpa.2016-0411-OA","article-title":"CK20 and p53 immunohistochemical staining patterns in urinary bladder specimens with equivocal atypia: correlation with outcomes","volume":"142","author":"Arias-Stella","year":"2018","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.prp.2022.153937_bib19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1746-1596-4-35","article-title":"Utility of a dual immunostain cocktail comprising of p53 and CK20 to aid in the diagnosis of non-neoplastic and neoplastic bladder biopsies","volume":"4","author":"Yildiz","year":"2009","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.prp.2022.153937_bib20","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/cyt.12386","article-title":"Evaluation of double immunocytochemical staining for CK20 and P53 as a potential adjunct to cytology for urothelial cancer diagnosis","volume":"28","author":"Lenos","year":"2017","journal-title":"Cytopathology"},{"key":"10.1016\/j.prp.2022.153937_bib21","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/4920236","article-title":"CK20 and CK5\/6 immunohistochemical staining of urothelial neoplasms: a perspective","volume":"2020","author":"Akhtar","year":"2020","journal-title":"Adv. Urol."},{"key":"10.1016\/j.prp.2022.153937_bib22","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1097\/PAS.0000000000000114","article-title":"Utility of a triple antibody cocktail intraurothelial neoplasm-3 (IUN-3-CK20\/CD44s\/p53) and \u03b1-methylacyl-CoA racemase (AMACR) in the distinction of urothelial carcinoma in situ (CIS) and reactive urothelial atypia","volume":"37","author":"Aron","year":"2013","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2022.153937_bib23","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.humpath.2020.02.008","article-title":"Immunohistochemical staining patterns of Ki-67 and p53 in florid reactive urothelial atypia and urothelial carcinoma in situ demonstrate significant overlap","volume":"98","author":"Nguyen","year":"2020","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2022.153937_bib24","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.humpath.2009.07.002","article-title":"Urothelial dysplasia and other flat lesions of the urinary bladder: clinicopathologic and molecular features","volume":"41","author":"Hodges","year":"2010","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2022.153937_bib25","doi-asserted-by":"crossref","first-page":"6512","DOI":"10.1158\/1078-0432.CCR-05-0891","article-title":"Molecular evidence supporting field effect in urothelial carcinogenesis","volume":"11","author":"Jones","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2022.153937_bib26","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/labinvest.3780074","article-title":"Clonality and genetic divergence in multifocal low-grade superficial urothelial carcinoma as determined by chromosome 9 and p53 deletion analysis","volume":"80","author":"Hartmann","year":"2000","journal-title":"Lab. Investig."},{"key":"10.1016\/j.prp.2022.153937_bib27","first-page":"809","article-title":"Occurrence of chromosome 9 and p53 alterations in multifocal dysplasia and carcinoma in situ of human urinary bladder","volume":"62","author":"Hartmann","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2022.153937_bib28","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/path.1175","article-title":"Patterns of chromosomal aberrations in urinary bladder tumours and adjacent urothelium","volume":"198","author":"Steidl","year":"2002","journal-title":"J. Pathol."},{"key":"10.1016\/j.prp.2022.153937_bib29","doi-asserted-by":"crossref","first-page":"13732","DOI":"10.1073\/pnas.0701771104","article-title":"Forerunner genes contiguous to RB1 contribute to the development of in situ neoplasia","volume":"104","author":"Lee","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.prp.2022.153937_bib30","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/PAI.0000000000000972","article-title":"HMB45\/PRAME, a novel double staining for the diagnosis of melanocytic neoplasms: technical aspects, results, and comparison with other commercially available staining (PRAME and Melan A\/PRAME)","volume":"30","author":"Grillini","year":"2022","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"10.1016\/j.prp.2022.153937_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2021.153637","article-title":"A preliminary study investigating the detection of lymhpovascular invasion in germ cell tumor of the testis with double staining for OCT4\/CD34","volume":"227","author":"Ricci","year":"2021","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2022.153937_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.153876","article-title":"Hematoxylin and eosin or double stain for CD34\/SOX10: which is better for the detection of lymphovascular invasion in cutaneous melanoma?","author":"Ricci","year":"2022","journal-title":"Pathol. Res. Pract."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033822001819?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033822001819?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:53:15Z","timestamp":1759733595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033822001819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":32,"alternative-id":["S0344033822001819"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2022.153937","relation":{},"ISSN":["0344-0338"],"issn-type":[{"type":"print","value":"0344-0338"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Could double stain for p53\/CK20 be a useful diagnostic tool for the appropriate classification of flat urothelial lesions?","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2022.153937","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"153937"}}